Tag: Teva

Pomerantz Law Firm Announces the Filing of a Class Action against Teva Pharmaceuticals Industries Limited and Certain Officers – TEVA

NEW YORK, Sept. 23, 2020 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Teva Pharmaceuticals Industries Limited  (“Teva” or the “Company”) (NYSE: TEVA) and certain of its officers.   The class action, filed in United States District Court for the Eastern District of Pennsylvania, and docketed under 20-cv-04660, is on behalf of a class consisting of all persons other than Defendants who purchased or otherwise, acquired Teva securities between October 29, 2015 and August 18, 2020, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

If you are a shareholder who purchased Teva securities during the class period,

Read More

Alfacalcidol Market 2020 SWOT Analysis and Key Business Strategies by Leading Players -Abcam, YaoPharma, Teva, Leo Pharma

The MarketWatch News Department was not involved in the creation of this content.

Sep 09, 2020 (Market Insight Reports) —
Alfacalcidol Market report 2020-2024: involves an in-depth understanding of the market and highly delivers market insights based on market intelligence studies. Adhering to industry norms, the report comprises chapter wise factual information spread across 100+ pages. Also, prepared by a panel of seasoned analysts, it offers the client with insightful data that establishes the base to take immediate steps ahead. Nonetheless, the market offers growth opportunities shortly exhibited in the best information format through this report.

The global Alfacalcidol market is expected to grow at a rapid pace during the forecast period 2020-2024.

Get a sample copy of this report:


Companies Covered (Revenue and Market Share)-

Abcam Plc (LON: ABC), YaoPharma, Teva Pharmaceutical Industries Limited (TLV: TEVA), Leo Pharma, Kunming Baker Norton Pharmaceutical, Tocris Bioscience, LGM Pharma, and

Read More